this should have a market cap of 100 million +, page-36

She is hard to get a handle on,so this may be causing some here to be confused....

Firstly you need to step back and look at her over the last 3years...

-Firstly a cap raising via an exercise of options for $8mil(which is as economic as the company could make it)

-Positive HCV results in combination with int/rib

-Positive HIV results

-Positive HIV/HCV results

The trials were conducted on small groups of 12 or 24 patients

They have done some pretty handy groundwork on a shoestring budget to prove up efficacy and safety.

-Strong Patent Protection.

-These trials i believe were conducted using a diluted liquid,since then they have developed a tablet form which is more easily absorbed meaning they can lower the dose of BIT225 for the same result.


All this for less than $6million ... maybe the reason they don't have a hundred mil market cap is because they don't tap the market every 6months.

Ultimately I believe they are inching their way to a bigger deal one step at a time.

GL Holders.